The effect of herpes simplex virus vector-mediated gene therapy of protein phosphatase 1α on bladder overactivity and nociception.
Tsuyoshi MajimaKenichi MoriKatsumi KadekawaShun TakaiYasuhito FunahashiBonnie ReinhartWilliam F GoinsMomokazu GotohJoseph C GloriosoEi-Ichiro TakaokaPublished in: Neurourology and urodynamics (2018)
HSV vectors-mediated PP1α gene therapy may be an alternative treatment modality for cystitis-related hypersensitive bladder condition at least in part via modulation of the IP3 R signaling pathway.